ArticleDiabetology & metabolic syndrome2022

Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report.

Tsuyoshi Okura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.